Author: admin | CATIE Blog

How HIV self-testing can help to reach the undiagnosed in Canada

November 9, 2022 • By Mallory Harrigan

Increasing access to HIV testing is crucial in the efforts to eliminate HIV as a public health threat in Canada. Testing is the first step for people with HIV to be able to start life-saving treatment. It is also important for people to know their status (whether positive or negative) so that they can prevent passing or getting HIV. HIV self-tests are a low-barrier option that can increase uptake of HIV testing for people who may not otherwise access it. Canada has made progress in reaching more of the undiagnosed, but access to testing is inequitable Estimates recently released by...

We have eight years left

November 9, 2022 • By Jody Jollimore

It’s been just over a month since I took the reins as CATIE’s new executive director, but the countdown is already on. We have less than eight years for Canada to eliminate HIV and hepatitis C as public health threats. In 1990, CATIE was founded as a treatment information hub for people living with HIV. Since then, the organization’s mandate has expanded, and we are now Canada’s knowledge broker for service providers working in HIV and hepatitis C prevention, testing, treatment and care. For most of CATIE’s history, an end goal to the epidemic has always seemed just out of...

A message from Laurie Edmiston

April 13, 2022 • By Laurie Edmiston

A message from Laurie Edmiston, executive director of CATIE: Dear friends and colleagues, It is with mixed emotions that I share with you my plans to retire this summer. As much as I love working at CATIE, there are many things I wish to do in life – maybe even during weekdays! In the nearly 19 years I’ve worked at CATIE, I have seen tremendous advances in science and in the community response to HIV and hepatitis C. When I joined the organization, our sole mandate was the provision of HIV treatment information. I’ve been honoured to lead our growth...

Hepatitis C reflex testing in Canada: from theory to practice

February 2, 2022 • By Romane Close

Hepatitis C testing in Canada can be complicated. Until recently, hepatitis C testing through provincial labs across the country was standard two-step testing. This approach uses two separate blood samples collected at two separate times. The first blood sample is for the screening test that looks for antibodies to the hepatitis C virus. This screening test determines if a person has ever been exposed to the virus. If this test result is positive, a second blood sample is taken to conduct the confirmatory test that looks for the presence of the hepatitis C virus in the blood. This test confirms...

Reframing Ontario’s overdose crisis: Addressing inhalation and stimulant use

November 1, 2021 • By Nick Boyce and Netta Kornberg

The overdose crisis in Ontario is often stereotyped as an “opioid injection” crisis. However, data show that significant numbers of overdoses are also being driven by stimulant drug use and inhalation drug use.

Understanding prescribing trends for hepatitis C treatment in Ontario

February 24, 2021 • By Mary Guyton, RN, Jennifer Broad and Kate Mason

The introduction and wide availability of direct-acting antivirals (DAAs) as a treatment for hepatitis C through a phased rollout from 2015 to 2018 held the promise of expanded access to treatment. These simpler treatments carried fewer clinical restrictions and required less specialist support, opening the possibility for primary care providers to treat their patients with hepatitis C. Given barriers to healthcare access for people who use drugs, those of us at the Toronto Community Hep C Program were curious to find out if this had in fact happened.